Lower Risk of One-Year Non-Relapse Mortality, Rapid Engraftment and Better NK Cell Recovery with GvHD Prophylaxis Based in Post-Transplant Cyclophosphamide/Bendamustine in Pediatric Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Ramirez, Oscar [1 ]
Portilla, Carlos Andres [1 ]
Buitrago, Jorge Luis [1 ]
Lopez, Eduardo [2 ]
机构：
[1] Ctr Med Imbanaco, Pediat Bone Marrow Transplantant Unit, Cali, Colombia
[2] Ctr Med Imbanaco, Pediat Infect Dis Dept, Cali, Colombia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
352
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Impact of post-transplant Cyclophosphamide(CYPT) for graft-versus-host Disease (GVHD) Prophylaxis in Allogenic Hematopoietic Stem Cell Transplantation (ALLO-HSCT). Unicentric Experience
    Cuellar Perez-Avila, Clara
    de Camino Gaisse, Begona Perez
    Cornago Navascues, Javier
    Lerma Verdejo, Ana
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 376 - 377
  • [32] Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis After Peripheral Blood Stem Cell HLA Identical Transplantation in Patients with Lymphoma: A Prospective Observational Study
    Bramanti, Stefania
    Taurino, Daniela
    Magri, Filippo
    De Philippis, Chiara
    Sarina, Barbara
    Castagna, Luca
    Giordano, Laura
    Mariotti, Jacopo
    Mannina, Daniele
    Santoro, Armando
    LIFE-BASEL, 2025, 15 (03):
  • [33] Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis
    Luo, Chengxin
    Huang, Xiangtao
    Wu, Guixian
    Huang, Yarui
    Ding, Yaqun
    Huang, Zhen
    Song, Qiuyue
    Chen, Jieping
    Li, Xi
    Xu, Shuangnian
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (01): : 32e1 - 32e15
  • [34] Haploidentical Stem Cell Transplantation (HAPLO-HSCT) with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis in high risk hematologic malignancies: Bone Marrow vs Peripheral Blood Stem Cell comparison
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Lopez-Corral, L.
    Heras, I.
    Pinana, J. L.
    Pascual, M. J.
    Bermudez, A.
    Caballero, D.
    Herrera, P.
    Castilla-Llorente, C.
    Solano, C.
    Anguita, J.
    Jimenez, S.
    Bento, L.
    Perez-Simon, A.
    Martin, C.
    Humala, K.
    Champ, D.
    Laiglesia, A.
    Montesinos, P.
    Buno, I.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S157 - S158
  • [35] The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide
    Jacopo Mariotti
    Angela Granata
    Stefania Bramanti
    Raynier Devillier
    Sabine Furst
    Barbara Sarina
    Samia Harbi
    Faezeh Legrand
    Catherine Faucher
    Pierre Jean Weiller
    Christian Chabannon
    Carmelo Carlo-Stella
    Armando Santoro
    Didier Blaise
    Luca Castagna
    Bone Marrow Transplantation, 2019, 54 : 1164 - 1167
  • [36] The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide
    Mariotti, Jacopo
    Granata, Angela
    Bramanti, Stefania
    Devillier, Raynier
    Furst, Sabine
    Sarina, Barbara
    Harbi, Samia
    Legrand, Faezeh
    Faucher, Catherine
    Weiller, Pierre Jean
    Chabannon, Christian
    Carlo-Stella, Carmelo
    Santoro, Armando
    Blaise, Didier
    Castagna, Luca
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1164 - 1167
  • [37] High pre-transplant Interleukin-18 is associated with Poor Hematopoietic Recovery after Allogeneic Stem Cell Transplantation and Predicts Increased non-relapse Mortality
    Kordelas, Lambros
    Radujkovic, Aleksandar
    Dai, Hao
    Bogdanov, Rashit
    Beelen, Dietrich W.
    Mueller-Tidow, Carsten
    Dreger, Peter
    Luft, Thomas
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 394 - 395
  • [38] Lower Absolute Lymphocyte Count Before Conditioning Predicts High Relapse Risk in Patients After Haploidentical Peripheral Blood Stem Cell Transplantation With Low Dose Anti-Thymocyte Globulin/Post-Transplant Cyclophosphamide for GvHD Prophylaxis
    Zhou, Xiao
    Cai, Yu
    Yang, Jun
    Tong, Yin
    Qiu, Huiying
    Huang, Chongmei
    Zhou, Kun
    Xu, Xiaowei
    Niu, Jiahua
    Xia, Xinxin
    Zhang, Ying
    Shen, Chang
    Wei, Yu
    Song, Xianmin
    Wan, Liping
    CELL TRANSPLANTATION, 2022, 31
  • [39] Myeloid-derived suppressor cell (MDSC) recovery after allogeneic hematopoietic cell transplantation (ALLOHCT) using post-transplant cyclophosphamide (PTCY) as graft-versus-host disease (GVHD) prophylaxis in children
    Oshrine, Benjamin
    Verdugo, Patrick
    Innamarato, Pasquale
    Pilon-Thomas, Shari
    BONE MARROW TRANSPLANTATION, 2019, 54 : 485 - 486
  • [40] Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Sampol, Antonia
    Montesinos, Pau
    Serrano, David
    Herrera, Pilar
    Jesus Pascual, Maria
    Bermudez, Arancha
    Castilla-Llorente, Cristina
    Bento, Leyre
    Champ, Diana
    Perez-Corral, Ana
    Buces, Elena
    Luis Diez-Martin, Jose
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S186 - S186
12345